Recent advances in the pathophysiologic understanding of the severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) infection has indicated that patients with severe …

The current outbreak of novel COVID-19 challenges the development of an efficient
treatment plan as soon as possible. Several promising treatment options stand out as …

Emergence of SARS-CoV-2 causing COVID-19 has resulted in hundreds of thousands of
deaths. In search for key targets of effective therapeutics, robust animal models mimicking …

Objective Previous studies that evaluated cardiovascular risk factors considered age as a
potential confounder. We aimed to investigate the impact of cardiovascular disease (CVD) …

Abstract Background Coronavirus disease 2019 (COVID-19) is a newly emerging infectious
disease and rapidly escalating epidemic caused by the severe acute respiratory syndrome …

Individuals suffering from severe viral respiratory tract infections have recently emerged as
“at risk” groups for developing invasive fungal infections. Influenza virus is one of the most …

Abstract Coronavirus disease 2019 (COVID‐19) is a global pandemic caused by severe
acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). The models that can accurately …

While SARS-CoV-2 primarily affects the lungs, the virus may be inflicting detriments to the
cardiovascular system, both directly through angiotensin-converting enzyme 2 receptor and …

Excessive monocyte/macrophage activation with the development of a cytokine storm and
subsequent acute lung injury, leading to acute respiratory distress syndrome (ARDS), is a …

Coronavirus disease 2019 (COVID-19), which reported in an outbreak in 2019 in Wuhan,
Hubei province, China, is caused by the SARS-CoV-2 virus. The virus belongs to the beta …